CRDF
Cardiff Oncology Inc
0.8896$
-2.5%
vs. previous close
Closing price · As of: Oct 30, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Cardiff Oncology Inc (CRDF) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 10/27/2026 | Current report (8-K) | Cardiff Oncology, Inc. (CRDF): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 10/22/2026 | Current report (8-K) | Cardiff Oncology, Inc. (CRDF): Submission of Matters to a Vote of Security Holders | View report ↗ |
| 09/14/2026 | Current report (8-K) | Cardiff Oncology, Inc. (CRDF): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 08/11/2026 | Current report (8-K) | Cardiff Oncology, Inc. (CRDF): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 07/16/2026 | Current report (8-K) | Cardiff Oncology, Inc. (CRDF): Entry into a Material Definitive Agreement; Other Events; Financial Statements and Exhibits | View report ↗ |
| 07/16/2026 | Capital measure | Form 424B5 filed with the SEC | View document ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.